Novartis News, Novartis Quote, NVS Quote

Novartis (NY:NVS) Delayed: 159.99 -3.1 (1.9%)

Prev. Close

$163.09

Today 6M 1Y 5Y

Open

$159.90

52 Wk High

$89.15

52 Wk Low

$69.84

Day High

$160.93

Day Low

$159.63

P/E

N/A

EPS

$0.00

Volume

1,294,012

Friends, Peers and Foes (?): NOVN, NOVN:SW, MRK, RNA, NVO (more...)

ALERTS | RSS

Sep 4, 2026 05:22 PM Form 6-K NOVARTIS AG For: Sep 04
Sep 4, 2026 04:52 PM Novartis pelacarsen trial fails to meet primary endpoint
Sep 4, 2026 06:06 AM Novartis (NOVN:SW) (NVS) PT Raised to CHF150 at BofA Securities
Sep 1, 2026 06:38 AM Premarket movers: GoPro soars 80% as Sono Group soars on Sports One deal
Sep 1, 2026 06:21 AM Form 6-K NOVARTIS AG For: Sep 01
Sep 1, 2026 06:04 AM Novartis MS drug remibrutinib meets Phase III trial goals
Jul 31, 2026 04:31 PM FDA approves Novartis Pluvicto for earlier-stage prostate cancer
Jul 28, 2026 04:58 AM Novartis (NOVN:SW) (NVS) PT Raised to CHF120 at Berenberg
Jul 23, 2026 07:34 AM Novartis (NOVN:SW) (NVS) PT Raised to CHF135 at CLSA
Jul 22, 2026 04:28 AM Novartis (NOVN:SW) (NVS) PT Raised to CHF142 at Citi

Entities mentioned with NVS

View All Entities